Mark A. Schlossberg

Mark A. Schlossberg

63 year
Health Technology
Consumer Non-Durables
Consumer Services

Profile

Mark A.
Schlossberg
served as an Independent Director at ImmunoCellular Therapeutics Ltd.
from 2015 to 2017.
He was a Director at Angiologix, Inc. and a Vice President at Amgen, Inc. from 2004 to 2011.
He also worked as a Principal at R.J.
Reynolds Tobacco Holdings, Inc. and as a Vice President-Law at Medtronic Trading Ltd.
Additionally, he served as the Secretary, Senior Vice President & General Counsel at Impax Laboratories LLC from 2012 to 2018 and as the Secretary, Senior VP-Legal & General Counsel at Cytokinetics, Inc. from 2011 to 2022.
Schlossberg received his undergraduate degree from the University of Southern California and his graduate degree from Emory University School of Law.

Former positions of Mark A. Schlossberg

CompaniesPositionEnd
CYTOKINETICS, INCORPORATED General Counsel 2022-05-12
General Counsel 2018-04-30
EOM PHARMACEUTICALS HOLDINGS, INC. Director/Board Member 2017-08-14
AMGEN INC. Corporate Officer/Principal 2011-04-30
Corporate Officer/Principal -
See the detail of Mark A. Schlossberg's experience

Training of Mark A. Schlossberg

University of Southern California Undergraduate Degree
Emory University School of Law Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mark A. Schlossberg's experience

Connections

100 +

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
AMGEN INC.

Health Technology

CYTOKINETICS, INCORPORATED

Health Technology

Private companies6

Consumer Non-Durables

Health Technology

Health Technology

Electronic Technology

Medtronic Trading Ltd.

Consumer Non-Durables

See company connections
  1. Stock Market
  2. Insiders
  3. Mark A. Schlossberg
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW